Cargando…

Identification of Host Proteins Predictive of Early Stage Mycobacterium tuberculosis Infection

The objective of this study was to identify blood-based protein biomarkers of early stage Mycobacterium tuberculosis (Mtb) infection. We utilized plasma and serum specimens from TB patients and their contacts (age ≥ 12) enrolled in a household contact study in Uganda. In the discovery phase cross-se...

Descripción completa

Detalles Bibliográficos
Autores principales: Bark, Charles M., Manceur, Ameur M., Malone, LaShaunda L., Nsereko, Mary, Okware, Brenda, Mayanja, Harriet K., Joloba, Moses L., Rajotte, Isabelle, Mentinova, Marija, Kay, Phyla, Lo, Seydina, Tremblay, Patrick, Stein, Catherine M., Boom, W. Henry, Paramithiotis, Eustache
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514433/
https://www.ncbi.nlm.nih.gov/pubmed/28655597
http://dx.doi.org/10.1016/j.ebiom.2017.06.019
Descripción
Sumario:The objective of this study was to identify blood-based protein biomarkers of early stage Mycobacterium tuberculosis (Mtb) infection. We utilized plasma and serum specimens from TB patients and their contacts (age ≥ 12) enrolled in a household contact study in Uganda. In the discovery phase cross-sectional samples from 104 HIV-uninfected persons classified as either active TB, latent Mtb infection (LTBI), tuberculin skin test (TST) converters, or persistent TST-negative were analyzed. Two hundred eighty-nine statistically significant (false discovery rate corrected p < 0.05) differentially expressed proteins were identified across all comparisons. Proteins associated with cellular immunity and lipid metabolism were induced early after Mtb infection. One hundred and fifty-nine proteins were selected for a targeted mass spectrometry assay. A set of longitudinal samples from 52 TST-negative subjects who converted to TST-positive or remained TST-negative were analyzed, and multivariate logistic regression was used to identify unique protein panels able to predict TST conversion with cross-validated AUC > 0.85. Panel performance was confirmed with an independent validation set of longitudinal samples from 16 subjects. These candidate protein biomarkers may allow for the identification of recently Mtb infected individuals at highest risk for developing active TB and most likely to benefit from preventive therapy.